What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Genentech
97%DGNews: Development of Growth Factor-Based Therapeutics for CNS Diseases
95%DGNews: Nutropin Human Growth Hormone for Turner Syndrome Cleared by FDA
95%DGNews: Nutropin Depot (Somatropin (rDNA)) Growth Hormone Available In The US
94%DGNews: Humatrope Recommended by FDA for Turner Syndrome
93%DGNews: FDA Advisory Committee Unanimously Recommends Approval For Raptiva (Efalizumab) As Potential Treatment For Moderate-To-Severe Plaque Psoriasis
93%DGNews: Pulmozyme for Cystic Fibrosis Cleared by the FDA
92%DGNews: Manufacturer of Efalizumab Announces Voluntary Withdrawal From US Market
92%DGNews: FDA Approves Avastin(R) (Bevacizumab) in Combination With Chemotherapy for First-Line Treatment of Most Common Type of Lung Cancer
92%DGNews: Lucentis (Ranibizumab) Appeared to Improve Vision in Patients With Wet Age-Related Macular Degeneration When Used in Combination With Visudyne (Verteporfin)
92%DGNews: FDA Approves TNKase (Tenecteplase) Single-Bolus Thrombolytic For Heart Attacks
91%DGNews: FDA Approves Avastin (Bevacizumab) in Combination With Chemotherapy for Second-Line Metastatic Colorectal Cancer Patients
91%DGNews: New Data on Cathflo Activase (Alteplase) in Pediatric Patients Presented at International Symposium on Endovascular Therapy
91%DGNews: FDA Approves Nutropin Depot For Pediatric Growth Hormone Deficiency
90%DGNews: FDA Approves Lucentis for the Treatment of Wet Age-Related Macular Degeneration
90%DGNews: Phase III Study of Avastin in Advanced Pancreatic Cancer Does Not Meet Primary Endpoint
90%DGNews: Preliminary Data Show Lucentis Improved Vision Compared to Visudyne in Patients with Wet Age-Related Macular Degeneration
90%DGNews: Tracleer (Bosentan) Study in Chronic Heart Failure Does Not Meet Primary Efficacy Objective
90%DGNews: SABCS: Fluorescence In Situ Hybridisation Assay More Accurate in Predicting Response to Gene Therapy in Breast Cancer
90%DGNews: New Drug for Non-Hodgkin's Lymphoma Now Available In The U.S.
90%DGNews: Ready-To-Use Nutropin AQ Approved For Adult Growth Hormone Deficiency
89%DGNews: Tanox, Inc. Announces Xolair (Omalizumab) Marketing Approval in Australia
89%DGNews: FDA Approves Zevalin (ibritumomab tiuxetan) for Treatment of Non-Hodgkin's Lymphoma
89%DGNews: FDA Advisory Committee Recommends Herceptin For Metastatic Breast Cancer
89%DGNews: Single-Bolus Thrombolytic, Metalyse (Tenecteplace, TNK-T-PA) Available In Europe
89%DGNews: Comparison of Two Heart Attack Drugs Fails to Prove Primary Endpoint
88%DGNews: Daily Oral Tablet, Tarceva (Erlotinib), For Advanced Non-Small Cell Lung Cancer
88%DGNews: FDA Approves Avastin (Bevacizumab, rhuMAb-VEGF) for Treatment of Metastatic Colon or Rectal Cancer
88%DGNews: SABCS: Herceptin (Trastuzumab) Works in Older Women with Metastatic Breast Cancer
88%DGNews: FDA Approves Cathflo Activase (Alteplase) To Clear Blocked Central Venous Access Devices
88%DGNews: AAAAI: Investigational Compound, olizumab/rhuMAb-E25, May Improve Asthma Control
88%DGNews: First New Drug for Non-Hodgkin's Lymphoma in Decade Cleared In U.S.
88%DGNews: FDA Approves Efficacy Results For Spine Bone Mineral Density
88%DGNews: ASCO-DG Dispatch: Herceptin Effective Against Most Aggressive Types Of Breast Cancer
88%DGNews: Activase for Brain Attack or Acute Ischemic Stroke Cleared by FDA
88%DGNews: Herceptin Lottery Ends, Trials Expand To Include More Eligible Patients
87%DGNews: Positive Results From a Randomized Phase 2 Study of Pertuzumab in Combination With Gemcitabine for Advanced Ovarian Cancer
87%DGNews: AAD: Raptiva (Efalizumab) Promising As Long-Term Treatment For Moderate-To-Severe Plaque Psoriasis
87%DGNews: ASCO: Rituxan (Rituximab) Plus Fludarabine Effective Front-line Therapy For Chronic Lymphocytic Leukemia
87%DGNews: Pulmozyme Approved For Kids With Cystic Fibrosis
87%DGNews: Drug Notification Issued For Pulmozyme (Dornase Alfa, Recombinant) Due To Packaging Defect
87%DGNews: AIDS Research to Focus on Management Therapy
87%DGNews: ASH: Radioactive Epratuzumab Shows Promising Results In Aggressive NHL
86%DGNews: FDA Warns of Safety Concern Regarding Rituxan in New Patient Population
86%DGNews: Data From Lucentis Pivotal Phase III Studies in Wet Age-Related Macular Degeneration in New England Journal of Medicine
86%DGNews: FDA/Genentech Warning on Avastin (Bevacizumab)
86%DGNews: Preliminary Results from a Phase 3b Study Showed Patients With Wet AMD Treated With Ranibizumab Quarterly Experienced a 16-Letter Benefit Over the Control Group at 1 Year
86%DGNews: FDA Approves Tercica's Increlex for Short Stature Caused by Severe Primary IGF-1 Deficiency
86%DGNews: ASCO GI: Higher Dose of Bevacizumab Safe and Effective as Addition to Colorectal Cancer Chemotherapy
86%DGNews: ACC: Aggressive Treatment Recommended For In-Hospital Heart Attacks
86%DGNews: ASH: Rituxan, In Combination, Appears Effective For Non-Hodgkin's Lymphoma
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.